Clinical Trials · NCT02255266
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,788
- Start date
- Mar 2015
- Locations
- 1 site, Italy
- Primary endpoint
- Frequency of patients achieving HbA1c reduction of at least 1%-point